Speeding up the Evaluation of New Agents in Cancer
Speeding up the Evaluation of New Agents in Cancer
Despite both the increase in basic biologic knowledge and the fact that many new agents have reached various stages of development during the last 10 years, the number of new treatments that have been approved for patients has not increased as expected. We propose the multi-arm, multi-stage trial design as …